Homocysteine-lowering trials for prevention of heart disease and stroke.
Dietary supplementation with B-vitamins that lower plasma total homocysteine concentrations are expected to lower the risk of cardiovascular disease. Folic acid and vitamin B (12) lower blood homocysteine concentrations by about 25-30% in populations without folic acid fortification, but by only 10-...
Egile nagusia: | Clarke, R |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
2005
|
Antzeko izenburuak
-
Homocysteine and prediction of coronary heart disease and stroke
nork: Clarke, R, et al.
Argitaratua: (2003) -
Homocysteine and vascular disease: Review of published results of the homocysteine-lowering trials
nork: Clarke, R, et al.
Argitaratua: (2011) -
Homocysteine and vascular disease: review of published results of the homocysteine-lowering trials.
nork: Clarke, R, et al.
Argitaratua: (2011) -
Homocysteine-lowering trials for prevention of vascular disease: protocol for a collaborative meta-analysis.
nork: Clarke, R, et al.
Argitaratua: (2007) -
Homocysteine and coronary heart disease.
nork: Clarke, R, et al.
Argitaratua: (2002)